{"filing":{"accession_number":"0001193125-26-338032","cik":"0001802255","ticker":"GRDN","company_name":"Guardian Pharmacy Services, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"d160709d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1802255/000119312526338032/d160709d8k.htm"},"events":[{"id":25632,"run_id":23263,"accession_number":"0001193125-26-338032","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Guardian Pharmacy Services issued a press release on August 6, 2026 reporting Q2 2026 financial results for the quarter ended June 30, 2026, including revenue of $351.8 million, net income of $22.1 million, and adjusted EBITDA of $29.7 million. The company also raised its full-year 2026 guidance. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1, which is the archetypal earnings_release event.","company_name":"Guardian Pharmacy Services, Inc.","ticker":"GRDN","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26516,"accession_number":"0001193125-26-338032","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Guardian Pharmacy Services issued a press release on August 6, 2026 reporting Q2 2026 financial results for the quarter ended June 30, 2026, including revenue of $351.8 million, net income of $22.1 million, and adjusted EBITDA of $29.7 million. The company also raised its full-year 2026 guidance. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1, which is the archetypal earnings_release event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:18:43.206965+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26516,"accession_number":"0001193125-26-338032","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Guardian Pharmacy Services issued a press release on August 6, 2026 reporting Q2 2026 financial results for the quarter ended June 30, 2026, including revenue of $351.8 million, net income of $22.1 million, and adjusted EBITDA of $29.7 million. The company also raised its full-year 2026 guidance. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1, which is the archetypal earnings_release event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:18:43.206965+00:00","company_name":"Guardian Pharmacy Services, Inc.","ticker":"GRDN","filing_date":"2026-08-06"}]}